Prolife Industries (NSE:PROLIFE) Accounts Receivable: ₹107.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:PROLIFE Prolife Industries Ltd NSE:PROLIFE
74 GF Score
Price ₹79.00
GF Value ₹156.57
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Prolife Industries Accounts Receivable?

Prolife Industries NSE:PROLIFE 74 Accounts Receivable is ₹107.2 Mil as of Mar. 2026. GuruFocus rates NSE:PROLIFE with a GF Score™ of 74/100 and a GF Value™ of ₹156.57 (Possible Value Trap). The stock has 3 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Prolife Industries's accounts receivables for the quarter that ended in Mar. 2026 was ₹107.2 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Prolife Industries's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹58.82.


Prolife Industries Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Prolife Industries's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=107.167/0*91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Prolife Industries's accounts receivable are only considered to be worth 75% of book value:

Prolife Industries's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(161.364+0.75 * 107.167+0.5 * 93.915-47.876
-0-0)/4.094
=58.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Prolife Industries Accounts Receivable Related Terms


Prolife Industries Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Prolife Industries's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prolife Industries Accounts Receivable Chart

Prolife Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.65 106.05 53.61 84.57 107.17

Prolife Industries Semi-Annual Data
Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.57 53.61 112.27 84.57 107.17
NSE:PROLIFE
74GF Score
Prolife Industries Ltd NSE:PROLIFE
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prolife Industries Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of ₹107.2 Mil mean?
Prolife Industries (NSE:PROLIFE) has a Accounts Receivable of ₹107.2 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Prolife Industries and its competitors.
Is Prolife Industries' Accounts Receivable too high?
Prolife Industries' current Accounts Receivable is ₹107.2 Mil. Overall, Prolife Industries has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prolife Industries' Accounts Receivable compare to DOW?
Prolife Industries' Accounts Receivable of ₹107.2 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Chemicals company?
A good Accounts Receivable depends on the Chemicals industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Prolife Industries and its competitors. Prolife Industries's current Accounts Receivable is ₹107.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolife Industries stock overvalued right now?
Based on GuruFocus' analysis, Prolife Industries (NSE:PROLIFE) is currently considered Possible Value Trap. The stock's GF Value™ is ₹156.57, compared to a current price of ₹79.00 — trading 49.5% below its estimated fair value. The current Accounts Receivable is ₹107.2 Mil. Prolife Industries' overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Prolife Industries (NSE:PROLIFE), the current Accounts Receivable is ₹107.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prolife Industries (NSE:PROLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, Prolife Industries stock appears to be undervalued. The current stock price of ₹79.00 is trading 49.5% below its estimated GF Value™ of ₹156.57. GuruFocus considers Prolife Industries to be Possible Value Trap.

Key valuation signals for NSE:PROLIFE:

  • Accounts Receivable: ₹107.2 Mil
  • GF Value™: ₹156.57 vs. price of ₹79.00 (49.5% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the NSE:PROLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prolife Industries Business Description

Address Plot No. 213, GIDC, Panoli Industrial Estate, District Bharuch, Ankleshwar, GJ, IND, 394116
Prolife Industries Ltd is engaged in the business of manufacturing of intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others. Its products include Dihydro Thio Para Toluidine Sulfonic Acid, Amino Methyl Phenoxy Sulfonic Acid, and others. The company derives revenue from both domestic and overseas markets, which are considered different geographical segments.
74GF Score

Get the complete analysis for NSE:PROLIFE

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹79.00
Price
₹156.57
GF Value